It Appears Many Americans Are Still Trusting Big Pharma

Big Pharma just never gives up. We’re currently in a lull period, but with winter coming in the Northern Hemisphere, you can bet there’ll be a push to get more and more people jabbed: seniors, pregnant women, children and babies; nothing is off limits. 

Half of Americans interested in getting updated COVID shot, Reuters/Ipsos poll shows

Pfizer’s share price has virtually halved since December 2021, which was a full year after the rollout of the jabs. 

It It was quite a successful investment for those 12 months. However, since then, it’s been on a steady decline. Pfizer ran out of people to jab. The campaign was getting tirep

So if you have Pfizer stock and lost 50% of your investment, you have two choices. You can sell your stock and write it off as a capital loss, or you can hang in there believing that the share price will go up again because Pfizer will come up with a cash cow to bolster its financial bottom line.

I don’t know if Pfizer is doing an extensive PR campaign in TV ads. However, it appears that many Americans are fearful enough and still primed to go back to the future and re-vaccinate themselves––how quickly people forget.

Perhaps the big-time investors are shorting the stock because they see the writing on the wall for class action lawsuits for all the damage done to people. A case is already underway, pushed forward by Queensland General Practitioner Dr Melissa McCann.

The proponents of the action claim negligence and misfeasance which caused people to suffer loss or damage, including but not limited to:

• personal injury;

• health care expenses;

• additional out-of-pocket expenses;

• economic loss;

• the need for gratuitous care and, additionally or alternatively, commercial care; and/or

• non-economic loss.

The other vaccine makers have seen their share prices drop as well, and it’s pretty likely that there will be lawsuits against those drug manufacturers.

People have to ask themselves, would they buy Pfizer or any other Big Pharma stock, knowing what we know? I have a principle: I don’t invest in any drug manufacturer. There are plenty of institutional investors that keep these companies afloat.was quite a successful investment for that 12-month period. However, since then, it’s been a steady decline. Pfizer ran out of people to jab. The campaign was getting tired and worn.

So if you happened to have Pfizer stock and you’ve lost 50% of your investment, you have two choices. You can sell your stock and write it off as a capital loss, or you can hang in there in the belief that the stock will go up again, because Pfizer will come up with a cash-cow to bolster its financial bottom line.

I don’t know if Pfizer is doing a big PR campaign in TV ads, but it appears that many Americans are fearful enough and still primed to go back to the future and re-vaccinate themselves––how quickly people forget.

Perhaps the big time investors are shorting the stock because they see the writing on the wall for class action lawsuits for all the damage done to people. There is already a lawsuit under way, pushed forward by Queensland General Practitioner, Dr Melissa McCann.

The proponents of the action claim negligence and misfeasance which caused people to suffer loss or damage, including but not limited to:

• personal injury;

• health care expenses;

• additional out-of-pocket expenses;

• economic loss;

• the need for gratuitous care and, additionally or alternatively, commercial care; and/or

• non-economic loss.

The other vaccine makers have seen their share prices drop as well, and it’s quite likely that there will be lawsuits against those drug manufacturers.

The questions people have to ask themselves is, would they buy Pfizer or any other Big Pharma stock, knowing what we know? I have a principle; I don’t invest in any drug manufacturer. There are plenty of institutional investors that keep these companies afloat.